Probiotics and GBS Colonization in Pregnancy
Launched by UNIVERSITY OF MODENA AND REGGIO EMILIA · Dec 13, 2021
Trial Information
Current as of April 29, 2025
Suspended
Keywords
ClinConnect Summary
Multicenter, randomized, placebo-controlled, double-blind, parallel group study aimed at evaluating the feasibility and effect of the use of probiotic starting from the 30th week, on vaginal / rectal colonization of GBS in women at low obstetric risk.
The study includes low obstetric risk pregnant women within the 33rd week of gestation, with vaginal delivery expected. It excludes women who during pregnancy had a positive urine culture for GBS, women with a previous newborn suffering from early sepsis, use of antibiotics in the month prior to enrollment, women unable to understand the stud...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • low obstetric risk pregnant women by the 33rd week of gestation,
- • vaginal delivery expected.
- Exclusion Criteria:
- • positive urine culture for GBS,
- • previous newborn suffering from early sepsis,
- • use of antibiotics in the month prior to enrollment,
- • women unable to understand the study and sign informed consent.
About University Of Modena And Reggio Emilia
The University of Modena and Reggio Emilia, a prestigious institution located in Italy, is renowned for its commitment to advancing medical research and education. With a strong focus on innovation and interdisciplinary collaboration, the university plays a pivotal role in conducting clinical trials that aim to improve healthcare outcomes. Its dedicated team of researchers and clinicians are engaged in cutting-edge studies across various medical fields, fostering an environment that encourages scientific inquiry and the translation of research findings into clinical practice. The university's robust infrastructure and emphasis on ethical standards ensure the integrity and reliability of its clinical trials, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Modena, , Italy
Milan, Mi, Italy
Reggio Emilia, Re, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials